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Cdc42 is a Rho-family small G protein that has been widely
studied for its role in controlling the actin cytoskeleton and
plays a part in several potentially oncogenic signaling networks.
Similar to most other small G proteins, Cdc42 binds to many
downstream effector proteins to elicit its cellular effects. These
effector proteins all engage the same face of Cdc42, the confor-
mation of which is governed by the activation state of the G
protein. Previously, the importance of individual residues in
conferring binding affinity has been explored for residues
within Cdc42 for three of its Cdc42/Rac interactive binding
(CRIB) effectors, activated Cdc42 kinase (ACK), p21-activated
kinase (PAK), andWiskott–Aldrich syndrome protein (WASP).
Here, in a complementary study, we have used our structure of
Cdc42 bound toACKvia an intrinsically disorderedACK region
to guide an analysis of the Cdc42 interface on ACK, creating a
panel of mutant proteins with which we can now describe the
complete energetic landscape of the Cdc42-binding site on
ACK.Our data suggest that the binding affinity of ACK relies on
several conserved residues that are critical for stabilizing the
quaternary structure. These residues are centered on the CRIB
region, with the complete binding region anchored at each end
by hydrophobic interactions. These findings suggest that ACK
adopts a dock and coalesce binding mechanism with Cdc42. In
contrast to other CRIB-family effectors and indeed other intrin-
sically disordered proteins, hydrophobic residues likely drive
Cdc42–ACK binding.
Cdc42 is a small G protein of the Rho family, which has
a well-established role in regulating the actin cytoskeleton,
being particularly associated with the formation of filopodia
(reviewed in Ref. 1). By regulating the cellular architecture,
Cdc42 also plays roles in cell motility, survival, and prolifera-
tion. Although the introduction of a Cdc42 mutant into fibro-
blasts showed hallmarks of transformation, activating muta-
tions of Cdc42 have not been found in human cancers (2). Gene
targeting, however, has demonstrated an essential role for
Cdc42 downstream of Ras (3). As such, it represents a potential
route to inhibit oncogenic signaling pathways driven by aber-
rant Ras activation.
The paradigm of G protein activation describes binding of
GTP, which results in an alteration in the structure of the G
proteins when the -phosphate of GTP forms hydrogen bonds
with residues in two flexible surface regions, switches I and II,
thus constraining them in a more rigid conformation that is
competent to bind effector proteins. The switch regions of Ha-
Ras have been demonstrated to adopt two different conforma-
tional states even in the GTP-bound, active form. State 1 is
analogous to the GDP-bound form, whereas state 2 is the con-
formation competent to engage effector proteins (4). For Ha-
Ras, state 2 is itself stabilized by effector binding and is suffi-
ciently populated to allow signal propagation. In contrast,
Cdc42 exhibits a far greater degree of flexibility even in the
active form, and crystal structures of Cdc42GDP and Cdc42
GMPPCP alongwith phosphorusNMR studies suggest that the
active and inactive forms of Cdc42 are conformationally simi-
lar. The presence of an effector protein shifts the equilibrium of
Cdc42GMPPCP3 and allows it to adopt the active conforma-
tion with rigidified switch regions (5).
Like many small G proteins, active Cdc42 interacts with a
large number of downstream effector proteins. One family of
these effectors is defined by a consensus sequence known as the
Cdc42/Rac interactive binding (CRIB) motif (6), contained
within their G protein–binding region (GBD). Several struc-
tures are available describing Cdc42 in complex with the GBDs
fromCRIB family effector proteins (7). In each, the GBD is seen
to wrap around the G protein, forming an intermolecular
-sheet and interacting with both the switch I and II regions
(8–10). A comparison of all of the available structures shows
that the CRIB consensus regions bind similarly to Cdc42, with
specificity determinants and major structural differences lying
outside thismotif in the remainder of theGBD sequences. Acti-
vated Cdc42-associated kinase (ACK) is one such CRIB effec-
tor. ACK binds Cdc42 with nanomolar affinity (8) and is, more-
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over, specific for Cdc42 to the exclusion of closely related Rho-
family G proteins, including Rac1 and TC10 (11, 12). ACK is a
non-receptor tyrosine kinase, which functions downstream of
growth factor receptors and has been implicated in survival,
neuronal signaling, and androgen receptor activation through
identification of its phosphorylation targets. ACK has also been
implicated as an important driver of tumorigenesis and there-
fore is itself a potential therapeutic target (reviewed in Ref. 13).
Interestingly, the Cdc42-binding region of ACK (GBD) has
the ability to reverse cellular transformation caused by expres-
sion of v-Ha-Ras in NIH3T3 fibroblasts (14). Promisingly,
fusion of a cell-penetrating sequence to the ACKGBD resulted
in a peptide that could enter cells and still retained the ability to
inhibit Ras-drivenphenotypes (14). Improvement of the affinity
and druglike properties of this Cdc42-binding sequence could
therefore generate a specific, competitive inhibitor for Cdc42
effector signaling with potential as a clinically useful inhibitor
for Ras-driven cancers. With this in mind, data pertaining to
the thermodynamics and mechanism of binding of the ACK
GBD to Cdc42 would be particularly useful to inform inhibitor
design.
ACK, like many signaling proteins, has a modular domain
architecture and contains several identifiable structured
domains (Fig. 1A). The GBD encompasses residues 448–489
(8) and is intrinsically disordered, showing no discernable sec-
ondary structurewhen free in solution andonly a short segment
of -strand even when complexed with Cdc42 (8). Intrinsically
disordered proteins (IDPs) or proteins containing intrinsically
disordered regions (IDRs) like ACK often function in signaling
pathways, with their disordered segments imparting a superior
level of control and regulation of the interactions they mediate
(15). The mechanism by which these proteins interact with
their target partners is referred to as coupled folding and bind-
ing. This has been refined into a sequentialmodel termed “dock
and coalesce.” Here, binding is initiated by one segment of the
IDR, which docks with a subsite on the partner protein inter-
face. This is rapidly followed by the coalesce phase, where the
remaining portions of the IDR bind to their cognate ancillary
sites (16, 17).
Although we have structural information on the complex,
there are few details on the mechanism of binding of ACK to
Cdc42. This system is particularly interesting because not only
is the ACK GBD disordered, but to some extent so is its target
binding site, because it involves the flexible switch regions of
Cdc42. The mechanism of binding to Cdc42 has been explored
for another member of the CRIB family of proteins, the
Wiskott–Aldrich syndrome protein (WASP) (18). In WASP,
the docking region has been identified as the basic region (BR)
at the N terminus of the GBD. Binding of the BR is the rate-
limiting step for complex formation, and coalescence occurs
very rapidly following docking (18). In fact, the importance of
the BR has been well documented because it underpins the
electrostatic steering mechanism utilized by WASP to contact
Cdc42 (19). A similar mechanism has been postulated for
PAK1, another member of the CRIB effector family (18). Fur-
thermore, formost of the systems studied involving IDPs, long-
range charge–charge interactions drive initial complex forma-
tion (17).
Previously, we have solved the structure of Cdc42 bound to
the ACK GBD (8). The conformation adopted by ACK in com-
plex with Cdc42 is significantly different from those of other
CRIB effector proteins. All of the CRIB proteins form a short
section of intermolecular -sheet with Cdc42. In addition,
WASP and PAK (PAK1 and -6) also form a -hairpin and short
-helix toward the C terminus of their GBD, whereas ACK is
otherwise unstructured. We have also undertaken thermody-
namic studies to identify the residues in the binding interface
on Cdc42 that contribute energetically to complex formation
(20) and the residues that allow ACK to discriminate between
Cdc42 and the closely related Rho family protein Rac1 (21).
These studies pinpointed several residues inACK that are likely
to interact with the key contributors to binding energy on
Cdc42. For instance, Val-42Cdc42 and Leu-174Cdc42 have been
identified as contributing a large fraction of the binding energy
between ACK and Cdc42, and these pack against Ile-463 and
Leu-449 in ACK, whereas the D38Amutant of Cdc42 results in
a 67-fold decrease in affinity and likely interacts with His-464
and His-467 of ACK in the complex structure.
Although a few individual residues in ACK have been
mutated in previous studies, to our knowledge, a comprehen-
sive screen has never been undertaken to dissect the energetic
landscape of the ACK GBD in complex with Cdc42. To obtain
the necessary data to direct a rational approach to using the
ACK GBD as the basis for an experimental or therapeutic tool
to inhibit Cdc42/Ras signaling and to obtain some mechanistic
insight into the ACK–Cdc42 binding process, we have under-
taken a thorough thermodynamic study on the ACK GBD. A
panel of residues in ACK was mutated to interrogate the ener-
getic environment of the Cdc42–ACK interaction. The data
reveal the full thermal map of the ACK binding surface and
indicate the critical input of conserved CRIB residues to stabi-
lizing the complex. In contrast to WASP and PAK, and indeed
several other IDP–target complexes, the initial encounter com-
plex of Cdc42 and ACK is unlikely to be driven by electrostatic
interaction but rather by hydrophobic interactions at the N
terminus of the region.
Results
Residue selection
The residues selected for mutation are shown in Fig. 1A.
First, we identified likely residues in ACK that were packed
closest to the Cdc42 hot spots (residues whose mutation
reduced ACK binding affinity  10-fold), using the Cdc42–
ACK complex structure (PDB code 1CF4) (8) and thermody-
namic data (20). The same structure was used to inform com-
putational predictions of the contribution of specific residues
usingmCSM (22), Robetta (23), and BeAtMuSiC (24). The out-
puts from the programs were quite different, so only those res-
idues that produced a predicted shift inG that was in the top
quartile in at least two programs were selected. Most residues
identified had already been selected, but four additional resi-
dues were included: Gln-452, Pro-457, Gln-459, and Asp-480.
Residues were also included if they were conserved across the
consensus regions of CRIB family proteins (Fig. 1B), which
expanded the selection to include Ile-454 and Ser-455. Finally,
ACK binding to Cdc42
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Leu-485 and Leu-487 were alsomutated because they had been
identified in the literature as potentially important in the
Cdc42–ACK interaction (25). All residues were changed to ala-
nine to allow calculation of the energetic contribution of their
side chains to the complex (26). Ala-451 was substituted with
aspartate to alter the hydrophobic character of this region and
potentially introduce steric clashes with Glu-178Cdc42.
Binding affinity analysis
The apparent Kd values for the interaction between the ACK
mutants and Cdc42 were determined by direct scintillation
proximity assays (SPAs). Example binding isotherms are shown
in Fig. 2 and the affinities are summarized in Table 1.
Of the 22 individual residues mutated, four (L449A, A451D,
S455A, and L487A) caused disruption of binding significantly
enough to raise the Kd at least 4-fold in direct binding experi-
ments. Six further mutations (I454A, P457A, S461A, F462A,
H464A, andH467A) destabilized the final complex so profoundly
that binding curves could not be obtained in these assays, because
data gathered at higher concentrations ( 2 M to achieve maxi-
mal binding) suffered from inaccuracy due to nonspecific binding
effects. Competition SPAs were therefore performed, by titrating
the mutant ACK peptides into a preformed complex of wild-type
ACK and Cdc42, to obtain more accurate quantitative data by
employing higher concentrations of the relevant ACK mutant.
Selected binding isotherms are shown in Fig. 3, and the affinities
are summarized in Table 2. These data accurately quantify the
binding affinities for these deleterious mutations, showing that
this subset ofmutationshave a large effect onKd, withdecreases in
affinity ranging from35- to1000-fold.
Interactions involving the conserved residues of the CRIBmotif
Because theCRIBmotif has been identified as a common and
conserved motif in Cdc42 and Rac1 effectors (6), it would be
expected to contain residues important for binding. The CRIB
Figure 1. A, domain architecture of ACK. Structural domains and regions with assigned functions are highlighted: sterile motif domain (SAM), nuclear
export signal (NES), tyrosine kinase domain (Kinase), Src homology 3 domain (SH3), GBD, clathrin-interacting region (Clath), EGFR-binding region/Mig6
homology region (ERR/MHR), and ubiquitin-associated domain (UBA). The GBD is expanded to show the sequence below and the selection of residues
in the ACK GBD that were selected for mutagenesis on the basis that they were most likely to be important in Cdc42 binding. Residues colored red were
identified by their proximity to hot spot Cdc42 residues discovered in our previous studies (8, 20). Residues colored blue were identified by computa-
tional predictions from a selection of programs as described under “Results.” Underlined residues are part of the conserved CRIB motif. B, sequence
alignment of ACK with other Cdc42/Rac-interacting proteins containing the CRIB motif. The residues and accession numbers for the Cdc42-binding
region of each protein are shown. The CRIB consensus motif is shown below the alignment. Residues in each protein that conform to the consensus are
highlighted in red.
Figure 2. Direct SPA binding data for the ACK GBD andmutant variants
withCdc42. The indicated concentrationof [3H]GTP-labeledCdc42was incu-
bated with GST-tagged ACK GBD variants, as appropriate, in each SPA. The
SPA signal was corrected by subtraction of the background signal from par-
allel measurements in which the effector protein was omitted. The effect of
the concentration of Cdc42 on this corrected SPA signal was fitted to a bind-
ing isotherm to give an apparent Kd value and the signal at saturating Cdc42
concentrations. The data and curve fits are displayed as a percentage of this
maximal signal.
ACK binding to Cdc42
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consensus has been defined as ISXPXXXXFXHXXHVG,
although several proteins do differ slightly; for instance, in
ACK, the penultimate valine is not present (Fig. 1B). Our data
demonstrate that several conserved residues of theCRIB region
are crucial in maintaining ACK binding affinity for Cdc42 and
quantify their contribution.
I454A (mutating the first conserved residue of the CRIB
motif) has the most dramatic effect of any single mutation
tested, binding of this mutant being undetectable in direct
SPAs, whereas the competition SPA gives a Kd 1000-fold
higher than wild type. Ile-454 is lodged in a hydrophobic
pocket, making extensive and clearly important contacts with
Leu-177, Ile-46, Gly-47, and Gly-48 of Cdc42 (Fig. 4A). S455A
(mutating the second CRIB conserved residue) has a less dra-
matic, although still influential, effect on binding; contacts to
Cdc42 seen in the structure are largely through the backbone at
this position.
Pro-457 (CRIB consensus residue 3) is part of a kink in the
ACK GBD that projects into a hydrophobic pocket (toward
Phe-169Cdc42, shown in Fig. 4B), andmutation to alanine has an
interesting effect on binding. P457A is one of the mutations
that produced poor data in direct binding assays. The compe-
tition data show that binding affinity for P457A is reduced to
around 4 M (Table 2), indicating that this mutation has an
190-fold effect on overall affinity. The protein backbone of
ACK bends tightly at Pro-457, and this residue likely stabilizes
the whole binding region in the correct orientation for binding.
In place of the proline, alanine should not disrupt the hydro-
phobic character of the region; however, the backbone of the
region would bemore flexible because proline fixes the angle,
whereas alanine hasmore rotational freedom. Pro-457 thus sta-
bilizes a section of the peptide into a relatively tight bend, which
follows the topography of Cdc42. Binding to Cdc42 demands a
loss of conformational entropy for theGBD (27); the ACKGBD
is unstructured when unbound but must adopt a specific
Table 1
Equilibrium binding constants and thermodynamic data for ACK GBD
mutants
Mutation Kda Increase Gb G
nM -fold cal/mol cal/mol
WT 44.2 3.2 10,027 -
L449A 491.5 3.7 11.1 8601 1426
S450A 167.1 19.4 3.8 9240 787
A451D 189.1 28.8 4.3 NAc NA
Q452A 44.0 4.5
I454A NDd 22.6e 8181 1846
S455A 243.1 42.5 5.5 9018 1009
P457A ND 22.6 8181 1846
Q459A 29.8 5.4
S461A ND 22.6 8181 1846
F462A ND 22.6 8181 1846
I463A 151.7 13.8 3.4 9297 730
H464A ND 22.6 8181 1846
T465A 85.4 10.3 1.9 9637 390
H467A ND 22.6 8181 1846
G468A 67.3 19.0 1.5 9778 249
D469A 38.0 4.9
S470A 35.4 5.5
W476A 137.0 24.4 3.1 9358 669
D480A 164.2 30.9 3.7 9250 777
R481A 107.4 10.7 2.4 9502 525
L485A 31.4 3.4
L487A 330.3 54.6 7.5 8837 1190
H464A/H467A ND 22.6 8181 1846
17 ND 22.6 8181 1846
a S.E. from curve fitting.
b Calculated using G RT lnKd1, where R 1.987 cal K1 mol1 and T 298
K.
c NA, mutation to Asp does not allow G calculation.
d ND, not determined (no binding); data that could not be fitted to the binding
isotherm.
e Assuming a Kd of 1 M (the limit of accurate direct SPA calculations).
Figure 3.Displacement of [3H]GTPCdc42 fromGST–WTACKGBDbyACK
GBD variants. Increasing concentrations of ACK GBD variants were titrated
into fixed concentrations of [3H]GTPCdc42 and GST–WT ACK GBD in compe-
tition SPAs. The Kd for Cdc42 binding to GST–WT ACK GBD was fixed to the
values obtained for this Kd in direct SPAs. The data were fitted to an isotherm
describing a pure competitionmodel to give an apparent Kd (Ki) value for the
ACK variants. The data and curve fits are displayed as a percentage of the
maximal SPA signal in each assay.
Table 2
Equilibrium binding constants and thermodynamic data for ACK GBD
mutants calculated from competition binding SPAs
Mutation Kda Increase Gb G
nM -fold cal/mol cal/mol
WT 20 5 10,497
I454A 19,730 2340 986.5 6415 4082
S455A 750 160 37.5 8351 2146
P457A 3830 500 191.5 7385 3112
S461A 4160 570 208.0 7336 3161
F462A 3460 700 173.0 7446 3051
H464A 2510 290 125.5 7636 2861
H467A 1790 170 89.5 7836 2661
H464A/H467A NDc
17 4760 110 238.0 7257 3240
a S.E. from curve fitting.
b Calculated using G RT lnKd1, where R 1.987 cal K1 mol1 and T 298
K.
c ND, not determined (no binding); data that could not be fitted to the binding
isotherm.
ACK binding to Cdc42
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Figure 4. A, schematic representation of part of the Cdc42–ACK GBD structure (8) showing the contacts made by Ile-454ACK. The van der Waals surfaces of
relevant residues are shown as a mesh. Cdc42 is colored green, and ACK is colored blue. B, schematic representation of part of the Cdc42–ACK GBD structure
showing the contacts made by Pro-457ACK. Coloring is as in A. C, schematic representation of part of the Cdc42–ACK GBD structure showing the contacts made
by Ser-461ACK andPhe-462ACK.Coloring is as inA.D, schematic representationof part of theCdc42–ACKGBDstructure showing the contactsmadebyHis-464ACK
andHis-467ACK. Coloring is as inA. E, schematic representation of part of the Cdc42–ACKGBD structure showing the contactsmade by Leu-449ACK. Coloring is as
in A. F, schematic representation of part of the Cdc42–ACK GBD structure showing the contacts made by Leu-485ACK and Leu-487ACK. Coloring is as in A. The
magnesium ion in the structureofCdc42 is shownas a vanderWaals surface and coloredorange.Wherehighlighted, oxygenatomsare colored red andnitrogen
in blue.
ACK binding to Cdc42
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conformer to bind. Proline replacement with alanine would
increase conformational entropy of the free GBD and therefore
the energetic cost of binding (28), accounting for the dramatic
lowering of the overall binding affinity observed.
Between Ser-461 and His-464 there is a region of the ACK
GBD that forms a small section of antiparallel -sheet with
Ala-41 toMet-45 of Cdc42 upon complex formation. The pres-
ence of this intermolecular -sheet is very common in small G
protein–effector complexes (7) and indicates the likely exist-
ence of hydrogen bonds across the interface. Mutation of Ser-
461, Phe-462, or His-464 disrupts complex formation signifi-
cantly (withmutation of Ile-463 showing amoremodest effect),
suggesting important side-chain interactions, with S461A and
F462A mutants causing particularly large decreases in binding
affinity (200- and 170-fold, respectively).
Data from the Cdc42–ACK structure suggest that the side
chain of Ser-461ACK can form hydrogen bonds with Thr-
43Cdc42 (Fig. 4C), whereas Phe-462ACK is positioned over a
hydrophobic patch on helix 1 of Cdc42 and is particularly
close to Ile-21 and Leu-20. Our structure shows that the back-
bone of Phe-462 contacts Tyr-40Cdc42 and Val-43Cdc42,
whereas its side chain contacts Leu-20Cdc42, Tyr-24Cdc42, and
Val-42Cdc42 (Fig. 4C). As the backbone chain in this region of
ACK interacts with the antiparallel  strand from residue 40 to
45 in Cdc42, forming the intermolecular -sheet, it is possible
that a large residue like Phe-462 is necessary to interactwith the
hydrophobic section of helix 1 while simultaneously allowing
the backbone to make favorable contacts with the -strand in
Cdc42.
I463AACK shows a slightly reduced affinity for Cdc42 of
around 3.5-fold. Mutation to alanine possibly disrupts the con-
tacts formed with the -carbon of Thr-43Cdc42 and with Ala-
41Cdc42. Val-42Cdc42 also lies close to Ile-463ACK, and this inter-
action is likely to be important, because the V42A mutation
is very disruptive for ACK–Cdc42 binding (20). However,
because this mutation has a relatively minor effect on binding
here and a previous double mutant cycle study that we under-
took concluded that the interaction betweenVal-42 and Ile-463
was not crucial to binding (27), the disruption due toV42ACdc42
mutation is more likely to be due to interaction with other crit-
ical residues, for instance Phe-462 (see above).
The two invariant histidines in the CRIB region, His-464ACK
and His-467ACK, have been identified as vital to CRIB effector
binding and have been mutated, either together or singly, to
prevent CRIB protein interaction inmany studies (29–32). The
residues are predicted to form hydrogen bonds with Asp-
38Cdc42, which are vital for CRIB–effector binding. These resi-
dues are not well defined in the Cdc42–ACK complex, but
D38ACdc42 causes a 67-fold reduction inACKbinding (8, 20). In
competition assays, Kd values for H464A and H467A were
increased 125- and 89-fold, respectively (Table 2). This demon-
strates that interactions with residues other than Asp-38Cdc42
are likely (e.g. His-464ACK also makes contacts with Phe-
37Cdc42 and Tyr-40Cdc42). Although the histidines contribute
significant binding energy, they are less critical, individually,
than all other CRIB consensus residues except Ser-455.We also
tested a double H464A/H467A mutant because this combina-
tion has been used in the literature as a non-binding mutant;
binding of H464A/H467A to Cdc42 was completely undetect-
able in both direct and competition SPAs. This indicates that
the combination of both histidines is necessary for stabilizing
the Cdc42–ACK complex and that their combined loss is fatal
to binding. Studies requiring a non-Cdc42 binding mutant of
ACKwould therefore be best facilitated using a double histidine
mutant or I454A.
Residues significantly affecting Cdc42 binding at the N
terminus of the ACK GBD
S450A andA451Dboth reduce the binding affinity for Cdc42
by4-fold. Ser-450 lies close to the carboxyl group of Glu-181
in various conformations of the family of NMR structures, pos-
sibly supplying a polar interaction here. A451D is potentially
sterically disruptive and alters the hydrophobic character of the
area, so it is of little surprise that it increases theKd.Mutation of
Leu-449 proved more significant, increasing the Kd 11-fold.
This residue forms significant contacts with Leu-174 (Fig. 4E).
Mutation of Leu-174Cdc42 to alanine has been shown to
increase the dissociation constant by 30-fold in previous work,
which also reported that L449Adecreases the affinity by 11-fold
(20, 27). The hydrophobic interaction between these leucines
is clearly important, in agreement with our previous study,
although mutation of Leu-174Cdc42 is more disruptive, poten-
tially due to its interactions with Ala-451ACK. Leu-449 contrib-
utes the most energy of any individual side chain outside the
CRIB to the total binding energy of the complex at 1.43 kcal/
mol, or 14.3% (as assessed in direct binding assays), indicating
an important role for the N terminus of the ACK GBD.
Energetic contributions at the C terminus of the ACK GBD
The W476A mutation in ACK gives rise to an 3-fold
increase in affinity for Cdc42. This relatively minor change is
likely due to the loss of a hydrophobic interaction with Phe-
28Cdc42, which is 4 Å from Phe-476ACK in the NMR structure
(8).
Mutation of Asp-480 to alanine increases the Kd of ACK for
Cdc42 by 4-fold; this is likely due to the loss of hydrogen
bonds between Asp-480ACK and Ser-83Cdc42. The mutant
R481A shows a more modest decrease in affinity of 2.4-fold to
107 nM. This residue adopts various conformations in theNMR
family of structures but most likely forms contacts with Tyr-
32Cdc42 and has the potential to form a hydrogen bond with
the backbone oxygen of Phe-28Cdc42. However, the flexibility
observed in theNMR structures suggests a degree of transience
in these interactions.
The leucines at positions 485 and 487 in the ACK GBD have
been postulated to interact with Leu-67 and Leu-70 of Cdc42
(8). Interestingly, the mutation L485A had no effect on Cdc42
binding, whereas L487A reduced the affinity 7.5-fold. From
examination of theNMR structure, Leu-485ACK forms contacts
with Leu-70Cdc42 but is also solvent-exposed, whereas Leu-
487ACK makes contacts with Thr-58–Gly-60Cdc42 and is
encased by Cdc42 residues in the complex structure. Poten-
tially, alanine can replace the hydrophobic interactions of Leu-
485ACK sufficiently so as not to disrupt the complex, whereas
Leu-487ACK, embedded in the complex, is more important and
ACK binding to Cdc42
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may well clamp the C-terminal end of the ACK GBD to Cdc42
(Fig. 4F).
Our data demonstrate that the majority of the energetically
important residues for the interaction betweenCdc42 andACK
are located toward the N terminus of the ACK GBD, so we
postulated that a C-terminally truncated form of the ACKGBD
might still retain reasonable affinity for Cdc42. Therefore, the
association of a truncated section of the ACKGBD terminating
at Pro-472 (named17)withCdc42was investigated. This pep-
tide retains the full CRIB consensus motif and the majority of
the energetically important residues identified in this study.
Although binding of this peptide could not be determined by
direct SPAs (Table 1), it did competewithwild-typeACK, albeit
with a significantly reduced affinity of 4.8 M (Table 2). The
removal of these 17 C-terminal residues had, however, only an
effect of similar magnitude to mutations of certain single resi-
dues (e.g. S461A) and proved less disruptive than either the
H464A/H467A double mutant or I454A. Overall, the 17 resi-
dues that comprise this part of the GBD provide3.2 kcal/mol
to the total binding energy (31%). It is possible, therefore, that
a shorter peptide based on the N-terminal sequence might still
bind tightly enough to Cdc42 to disrupt the Cdc42 interaction
with ACK and other CRIB effector proteins via this crucial
region.
Energetically neutral residues
ACK mutations Q452A, Q459A, D469A, S470A, and L485A
produced no changes in Cdc42 binding despite being identified
as being either near energetic hot spots on Cdc42 or flagged up
by computational predictions. Because these residues do not
seem to contribute thermodynamically to the Cdc42–ACK
binding interface, they represent an important cohort of resi-
dues that could be changed to improve binding.
Kinetics of the interaction between ACK and Cdc42
The WASP–Cdc42 interaction has been demonstrated to
occur using a dock and coalesce mechanism driven by electro-
statics (18, 19). We were interested, therefore, in analyzing the
kinetics of the ACK–Cdc42 interaction to see whether a similar
mechanism of binding was utilized. We analyzed the ACK–
Cdc42 interaction using bio-layer inferometry (BLI), and the
results are shown in Fig. 5. Summaries of the kinetic data are
shown in A and B, with representative raw data in C.
The overall affinity of ACK–Cdc42 was calculated to be
130 nM, in good agreement with the SPA data. The on-rate
was 0.224 M1 s1, whereas the off-rate was 28 ms1. For
comparison, we also undertook a similar analysis for WASP–
Cdc42 and a variant of WASP lacking the electrostatic steering
region (BR). The WASP–Cdc42 affinity was calculated to be
30 nM, tighter than the ACK–Cdc42 complex and in agree-
ment with previous data (20). The higher affinity of WASP for
Cdc42 is driven by a 3-fold increase in its kon to 0.793M1 s1
compared with that of ACK, in conjunction with a similar off-
rate of20ms1, as might be expected for a CRIB protein with
an electrostatic steering region. The WASP BR variant (with
all six basic residues at the N terminus of the WASP GBD
mutated to alanine) showed an affinity of220 nM, comprising
an on-rate of 0.360 M1 s1 and an off-rate of 77 ms1. The
on-rate ofWASPBR is half that ofWASP and closer to that of
ACK, as would be predicted from the loss of the steering resi-
dues. Interestingly, however, the lower affinity of the mutant is
also due to a much faster off-rate (4-fold higher) thanWASP.
To identify the residues involved in the docking phase of the
ACK–Cdc42 interaction, we attempted to analyze our ACK
mutant variants by BLI, rationalizing that mutation of these
residues would result in a decrease in ACK kon. However,
because the affinity of these ACK mutant variants was compa-
rably low, high concentrations of protein would be required to
obtain useable data. Unfortunately, the higher concentrations
of protein led to increased levels of nonspecific binding, and the
BLI data became unreliable, preventing further analysis.
Discussion
The data presented here indicate several residues that are key
to Cdc42–ACK binding, and these are centered on the CRIB
region. An overall summary of the relative contribution that
each ACK residue of the GBDmakes to the Cdc42–ACK com-
plex is shown in Fig. 6A. How these energetic contributions
maponto the structure of the complex is shown in Fig. 6B, along
with the complementary contributions of the Cdc42 residues.
Overall, most binding energy resides in the center of the ACK
GBD, concentrated in CRIB consensus residues. The region is
anchored to Cdc42 at each end by hydrophobic interactions.
We therefore envisage that initial docking is mediated by the
N-terminal region of the ACK GBD in a manner akin to the
electrostatic steering or basic region docking demonstrated for
Cdc42-WASP and postulated for Cdc42-PAK (18, 19) but dif-
fering significantly by being driven by hydrophobic contacts.
The patch of residues on ACK comprising Leu-449, Ser-450,
and Ala-451, contacts Cdc42 via residues in helix 5 and the C
terminus of the protein (e.g. Glu-181Cdc42). This region is not
subject to the rearrangements experienced by the switches and
would provide a relatively stable platform to mediate the initial
docking phase of complex formation and therefore facilitate
molecular recognition for the two partners. This hydrophobic
patch interaction would be further extended by Ile-454ACK,
which contacts Leu-177, Ile-46, Gly-47, and Gly-48Cdc42, all of
which are structurally stable, nucleotide-independent residues.
The hydrophobic potential of the surface of Cdc42 is shown in
Fig. 7. An intense concentration of hydrophobic potential is
seen on Cdc42, complementing the N-terminal hydrophobic
residues of ACK (Fig. 7, A and B). Although other regions of
hydrophobicity are seen on Cdc42 (Fig. 7, C–E), none are com-
parable with the density seen at this pocket, giving it plausible
docking potential. This hydrophobic potential is also seen in
free Cdc42 in the active form (Fig. 7F) and sowould be available
to form an encounter complex. Interestingly, the same intensity
of hydrophobic potential is absent from the surface of Rac1 (to
which ACK does not bind), where the presence of Arg-174 at
least partially disrupts the potential (Fig. 7G). Leu-174Cdc42 was
identified previously as a specificity determinant for ACKbind-
ing (20).
It is well accepted that small G proteins like Cdc42 are only
able to bind effectors when bound to GTP. However, it appears
that the native structure of Cdc42 changes little on nucleotide
exchange and is possibly only finally stabilized in the active
ACK binding to Cdc42
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conformation on effector binding (5). The mechanism sug-
gested to underpin this involves the effector initially binding
loosely, creating a favorable hydrophobic cleft around Phe-
37Cdc42 and Val-36Cdc42 (in our previous study, V36A was
found to decrease binding affinity  10-fold (20)). The result-
ing movement of switch I is then stabilized by Thr-35Cdc42
coordination to the -phosphate of GTP and to Mg2	. When
GDP is bound, this cannot occur, and the effector complex is
transitory; likewise, without the effector protein, the active con-
formation is also transitory (5).
In this model, ACK residues in the vicinity of Phe-37Cdc42
andThr-35Cdc42 would be of critical importance. The section of
ACK between Ser-461 andHis-467 contains a concentration of
residues that our data indicate are vital for binding (Fig. 6). The
most important appear to allow the GBD to interact with two
distinct surfaces of Cdc42, strand 2 (forming the intermolec-
ular -sheet) and helix 1 of Cdc42, inserting between these to
stabilize the quaternary complex (Fig. 6B). His-467ACK, which
faces away fromVal-36Cdc42 but is close enough to Asp-63Cdc42
for a polar interaction (Fig. 4D), contributes a hydrogen bond
(predicted by our structural data). It is possible that this asso-
ciation provides a key point of contact with switch II, allowing
formation of the required hydrophobic cleft for stable effector
association. His-464ACK contacts Phe-37Cdc42 and so would
also contribute to stabilizing switch I. After initial docking, it
seems that the conserved histidines of the CRIB, assisted by
other nearby residues, help to grasp switches I and II and create
an environment where Thr-35Cdc42 can interact both with the
-phosphate of GTP andMg2	 to create a stable complex. Key
mutations in the central CRIB region would destabilize this
coalescence part of complex formation, as observed in the poor
binding affinities of CRIB mutants.
Thus, ACK could bind Cdc42 in an initial, transient manner
mediated by the N-terminal region of the GBD constituting the
docking or encounter complex (Fig. 7B). Residues such as Ile-
454ACK,whosemutation disrupts binding profoundly, are likely
to be involved in docking complex formation via interaction
with stable, structured regions of Cdc42. These stabilize the
initial encounter complex by forming bracing interactions with
less flexible Cdc42 residues. Subsequent interaction, probably
by contacts to switch I, would then initiate coalescence of the
second section of the complex, stabilizing the active conforma-
tions of the switch regions of Cdc42 and locking the ACKGBD
in its binding configuration. Mutation of certain critical side
chains (e.g. Ser-461ACK or Phe-462ACK), however, would hinder
the stabilization of the bound structure in a similar manner to
the absence of the -phosphate in the GDP-bound form. Thus,
unlikemany IDP interactions, where the target protein is struc-
tured, in the Cdc42–ACK complex, the disordered structure of
both the effector and the target binding interface are together
stabilized into the active signal-transducing conformation by a
reciprocal rigidifying mechanism.
In light of this new data set, we can match the effects of
mutation in the ACK GBD to the other side of the binding
interface. Twomutations inCdc42 that had a significant impact
on ACK binding were F37A and D38A. These residues lie close
to theCRIB region ofACK in the structure, and the histidines at
positions 464 and 467 have been identified as forming hydrogen
Figure5.Bindingkinetics forACK,WASP, andWASPBRmeasuredbybio-layer inferometry.GST fusionproteinswere loadedonto anti-GST sensors and
dipped alternately into a concentration rangeof Cdc42GMPPNP (of at least threedifferent concentrations) andbuffer tomeasure on- andoff-rates.A, the table
shows themean values for kon, koff, and Kdwith S.E., wheren 3–9 independent experiments.B, the samedata as summarized inAplotted asbox plots (analysis
performed in R). C, raw data from representative experiments. Error bars, S.E.
Figure 6. A, schematic representation of the ACK GBD with residues scaled by size relative to their contribution to Cdc42 binding affinity. Residues whose
mutation causes
 3-fold increase in Kd are colored green; those whose mutation causes a 3–12-fold increase are colored orange; and those whose mutation
causes a 12-fold increase are shown in red. B, structural and thermodynamic details of the Cdc42–ACK complex (PDB entry 1CF4). Left, the van der Waals
surface of Cdc42 as a green mesh; residues whose mutation causes a 3–12-fold increase in Kd are colored orange, and those leading to a12-fold increase are
colored red and labeled. ACK residues 448–489 are shown as a schematic in blue. The N terminus of ACK is labeled. Right, structure of Cdc42 as a schematic in
green. The van der Waals surface of ACK residues 448–489 is shown as a blue mesh, residues whose mutation causes a 3–12-fold increase in Kd are colored
orange, and those leading to a 12-fold increase are colored red and labeled. -Strand 2 and -helix 1 of Cdc42 are labeled accordingly.
ACK binding to Cdc42
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bonds with Asp-38 in several CRIB–Cdc42 complexes, as dis-
cussed earlier. Conserved CRIB residues, such as His-467, His-
464, and Phe-462 of ACK, which surround residues 37–40 on
Cdc42, have been shown in this study to be important for sta-
bilizing the ACK–Cdc42 complex and so match the mutation
data found previously.
F56WCdc42 was previously suggested to be a mutation
thought to disrupt the topography of Cdc42 that is appropriate
for ACK binding, because it does not form direct contacts with
ACK but does alter the complex binding affinity (21). Phe-
56Cdc42 packs behind Phe-37Cdc42 andAsp-38Cdc42, which have
been implicated in binding specificity. This is consistent also
with a model where effector binding stabilizes switch I, sand-
wiching it between Cdc42 and the GBD. F567W disrupts the
packing behind switch I and prevents the stable conformation
forming that allows secure effector binding.
Comparing Cdc42 effector proteins
ACK and WASP are both Cdc42-specific CRIB effectors,
whereas PAK1 is not (being able to also bind Rac1), and the
CRIB regions bind to Cdc42 in a similar manner. Comparison
of the structures, togetherwith thermodynamic data, is inform-
ative in deciding which interactions may be Cdc42-specific.
N-terminal to the CRIB, the hydrophobic interactions
around Leu-449 appear crucial for ACK binding to Cdc42.
There is a degree of conservation at least in the character of the
residue at the position analogous to Leu-449ACK among other
Cdc42-specific effectors, as seen in Fig. 1B. In theCdc42-WASP
structure, theN-terminal region of the GBD is in contact with a
similar region of Cdc42 to theACK-binding region. Ile-273 (the
equivalent residue) inWASP occupies a position similar to that
of Leu-449 of ACK, close to Leu-174Cdc42 and even closer to
Leu-177Cdc42. This region differs in the PAKs and lies outside of
the region necessary for high-affinity PAK1 binding to Cdc42
(33); indeed, the L174Amutation in Cdc42 has aminimal effect
onPAK1binding. Because PAK1 is amore promiscuous binder,
the Leu-174/Leu-449 interaction appears to be an important
determinant for specific Cdc42 binding. Another Cdc42-spe-
cific effector, Cdc42SE2 (or SPEC2) (34), has an isoleucine at
this position, complementing the theory that a bulky hydro-
phobic residue here is key for a CRIB protein that is specific for
Cdc42. In Rac1 and RhoA, Leu-174Cdc42 is replaced by an argi-
nine, which would clash with the bulky hydrophobic Leu/Ile in
the Cdc42-specific effectors, in contrast to the stabilizing influ-
ence provided by Leu-174 in Cdc42 (Fig. 4E).
Pro-457 and Ser-461, which are crucial for ACK binding, are
also present inWASP; however, two of the intervening residues
aremissing. Ser-242WASP, like Ser-461ACK, lies very close to the
backbone hydroxyl of Thr-43Cdc42, potentially forming a simi-
larly important hydrogen bond.However, Pro-241WASP (equiv-
alent to Pro-457ACK) is now adjacent to Ser-242WASP, so there
is likely some difference in this residue’s contribution to bind-
ing in WASP–Cdc42. With the ACK sequence being slightly
longer than WASP here, the kink that is stabilized in the ACK
peptide chain aroundPro-457may be important in allowing the
ACK chain to occupy the optimal position on the surface of
Cdc42; indeed, the proline appears in a similar position but
buried deeper in the ACK–Cdc42 structure than that of
WASP–Cdc42, facilitated by the extra residues. Overall, the
GBD topography between effectors is similar between the con-
served Ile-454 and His-467 (ACK numbering), with the caveat
that ACK is able to insert deeper into the Cdc42 structure
between helix 1 and the C-terminal end of switch II due to its
extended sequence in this region. This region is important for
ACK binding affinity, but possibly less so for distinguishing
between different CRIB effectors (ACK relies on Val-42,
whereasWASP and PAK1 can still bindwithout it; Rac1 has the
smaller Ala at this position, which may discourage ACK bind-
ing). It is notable from our kinetic data that, once the basic
region residues of WASP have been removed, the off-rate for
Figure 7. A, schematic representation of the Cdc42–ACK structure (PDB entry
1CF4). Cdc42 is shown in gray, with hydrophobic residues (Ala, Gly, Val, Ile,
Leu, Phe, andMet) colored orange. ACK is shown in blue, and its N terminus is
labeled. B, van der Waals surface of Cdc42–ACK structure shown in the same
orientation as in A. The van der Waals surface of Cdc42 is solid, whereas ACK
residues 448–489 are shown as a blue mesh. C, as in B, but with the Cdc42–
ACK structure rotated 90° around the vertical, anti-clockwise. D, as in B, but
with the Cdc42–ACK structure rotated 180° around the vertical, anti-clock-
wise. E, as in B, but with the Cdc42–ACK structure rotated 270° around the
vertical, anti-clockwise. F, van der Waals surface of Cdc42GMPPCP shown in
gray, with hydrophobic residues (Ala, Gly, Val, Ile, Leu, Phe, and Met) colored
orange. Leu-174, Leu-177, Ile-46, Gly-47, and Gly-48 are shown in red (PDB
entry 2QRZ). Switch I residues are colored blue. G, van der Waals surface of
Rac1 Q61LGMPPNP shown in gray, with hydrophobic residues (Ala, Gly, Val,
Ile, Leu, Phe, and Met) colored orange. Arg-174 is shown in green (PDB entry
2GZL). Switch I residues are colored blue.
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WASP is shown to be faster than that for ACK (Fig. 5). This is
possibly due to the more superficial interactions between
Cdc42 and WASP dictated by this region.
Val-42Cdc42 is an interesting discriminatory residue in that
its mutation affects ACK but not WASP or PAK1 (20). This
residue is proximal to Phe-462 and Ile-463 in ACK, both of
which could interact with the hydrophobic side chain; however,
because only the phenylalanine is conserved across CRIB effec-
tors, the discrimination is likely to be due to Ile-463. I463AACK,
however, only reduces the affinity 3.5-fold, which cannot
explain the nearly 20-fold decrease generated by V42ACdc42. As
the comparison of the structures has shown, ACK inserts
deeper into Cdc42, whereas WASP simply lies over the C ter-
minus of switch II, which could allow Phe-462ACK improved
access to Val-42Cdc42 and mean that the hydrophobic interac-
tion here is more important than for other Cdc42 effectors.
Toward the C terminus of the GBD, fewer residues in ACK
appear important for the binding affinity, although, since they
overlie switch I, they likely help pin the entire active conforma-
tion of Cdc42 into place. In agreement with the overall charac-
ter of the Cdc42–ACK binding interface, both ends are in fact
tied down by important hydrophobic interactions (Figs. 6
and 7).
Biological implications
The differences between the WASP and ACK GBDs and
their respective binding mechanisms with Cdc42 likely reflect
evolutionary responses to the different roles of the GBDs in the
complete effector proteins. The negative regulation of WASP
(and indeedPAK1 (35)) by intramolecular interactions between
the GBD and functional domains, which are relieved by the
binding of Cdc42 to the GBD, is well documented (36). The
regulation of ACK is less well understood, and despite signifi-
cant attempts to unravel interactions governing its activity,
results continue to be contradictory. Analysis is hampered by
the fact that ACK function is often measured in terms of its
kinase activity, when ACK clearly has kinase-independent cel-
lular functions. Two levels of intramolecular regulatory inter-
actions in ACK do seem likely, however: the inhibitory interac-
tion between the MHR and the kinase domain (37) and
dimerization (probably via the SAM domain) that activates
kinase activity (38). However, despite ACK being initially iden-
tified as an effector for Cdc42, it now seems unlikely that bind-
ing of Cdc42 directly stimulates the kinase activity of ACK. Any
increase in activity seen in cells is more likely due to subcellular
localization effects. It therefore seems evident, at least from
information currently available, that the ACK GBD is freely
available to associate with Cdc42. These differences are
reflected in the relative affinities of the isolated GBDs and the
full-length proteins for Cdc42. InWASP, theGBD binds Cdc42
significantly tighter (100 times) than the full-length protein
(9, 39), whereas for ACK, the GBD and longer constructs bind
with similar affinity (11). The corollary of this scenario is that
WASP needs to form an encounter complex for Cdc42 that
utilizes residues outside the GBD, which are available for inter-
action even in its autoinhibited conformation. Because the
ACK GBD is not involved in intramolecular interactions, it is
free to steer recognition of Cdc42 itself. This is reflected in the
lower Ka measured for ACK–Cdc42 in comparison with
WASP–Cdc42.
One of the driving forces for this analysis of the Cd42–ACK
binding interface was to generate data to inform rational ther-
apeutic design. The full ACK GBD used to solve the Cdc42–
ACK structure has been shown to reverse Ras-driven transfor-
mationwhen introduced into cell lines (14). The data presented
here demonstrate that themajority of the binding energy of the
ACK GBD resides between Leu-449 and His-467; thus, a pep-
tide containing at least these residues would provide an excel-
lent starting point for a therapeutic. These data also define the
target region of chemical space for fragment-based drug design.
Furthermore, by highlighting residues that do not contribute to
the Cdc42–ACK interface, important points are identified at
which a peptide could be engineered with increased affinity, by
substituting amino acids that introduce further favorable con-
tacts with Cdc42. It is also notable that ACK lacks the electro-
static steering mechanism employed by WASP and probably
PAK1. It is possible, therefore, that the addition of a positively
chargedmotif to the N terminus of ACK could further increase
binding of this effector to Cdc42, by exploiting the negatively
charged patch provided by Glu-49 and Glu-178 on Cdc42 and
increasing the on-rate of ACK to WASP levels (19).
Conclusion
A model of Cdc42–effector binding involving a dock and
coalesce mechanism initiated by electrostatic steering is evolv-
ing, where the interaction with the effector protein stabilizes
switch I in the active conformation, bringing the effector GBD
and the flexible parts of Cdc42 into a stable quaternary struc-
ture (5, 18). Binding data presented here for Cdc42–ACK cor-
relatewith thismodel. Energetically important residues inACK
are primarily concentrated in the N terminus and CRIB con-
sensus of the GBD (Fig. 6). Like WASP, ACK may also bind
initially via its N-terminal energetic hot spot, where the com-
plementary Cdc42 structure is more rigid regardless of activa-
tion state and would therefore provide a good docking subsite.
In the case of WASP, and possibly PAK1, this is assisted by a
polylysine-directed electrostatic steering mechanism, with the
steering section not an energetically important part of the final
complex. In ACK, the encounter would be directed by hydro-
phobic interactions that also remain as part of the final complex
(Fig. 7). Following N-terminal docking, the remainder of the
ACKGBD can wrap around Cdc42, stabilizing switches I and II
in their active conformation and leading to a final structured,
stable, quaternary complex. Several consensus CRIB residues
toward the center of the GBD are vital in the stability of this
final structure, inserting between switch I and helix 1 of
Cdc42. The similarity of these residues between CRIB effectors
implies that they are not key to the specificity ofACK forCdc42.
The C-terminal region of the GBD contributes to the overall
binding affinity through several dispersed residues.
The data reported here support a dock and coalesce mecha-
nism for ACK and suggest that this could describe a general
mechanism whereby these unstructured GBDs interact with
their cognate small G protein in common with many intrinsi-
cally disordered proteins. Cdc42–ACK, however, represents a
new category of this type of interaction being instigated by
ACK binding to Cdc42
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hydrophobic contacts. Initial docking is mediated by a hydro-
phobic patch on ACK, whichmay perform a role similar to that
of the electrostatic steering region of other CRIB effectors. This
is followed by the coalesce phase, mediated by the CRIB motif,
which orientates Phe-37Cdc42, allowing Cdc42GTP to lock into
the active “state 2” conformation. The rest of the binding inter-
face then zips up, and residues on Cdc42 clip ACK into place to
form the final stable complex.
Experimental procedures
Protein expression constructs
Proteins were expressed in pGEX-2T vectors (Amersham
Biosciences) as GST fusion proteins. The constructs ex-
pressing ACK(448–489) (8) and Cdc42 7 Q61L (21) have
been described previously.
Mutagenesis
Residues weremutated to alanine, with the exception of Ala-
451, whichwasmutated to aspartate. Site-directedmutagenesis
on ACK(448–489) was performed using the QuikChange
Lightning multisite-directed mutagenesis kit (Agilent), and
mutations were confirmed by sequencing (Department of Bio-
chemistry DNA Sequencing Facility, University of Cambridge).
Recombinant protein production
Escherichia coli BL21 cells were used to express recombinant
proteins. Stationary cultures were diluted in fresh 2TY growth
medium (1:10) and grown to A600 0.7–0.9 at 37 °C, whereupon
theywere inducedwith isopropyl--D-1-thiogalactopyranoside
(0.1mM) for 5 h. Proteins were affinity-purified on glutathione-
agarose resin (Sigma-Aldrich). Cdc42 and ACK mutants used
for competition assays were cleaved from GST using thrombin
(Novagen), whereas GST–ACK proteins for direct binding
assays were eluted from the resin in 10mM reduced glutathione
(in 50mMTris–HCl, 150mMNaCl, pH 7.5). Cdc42 and cleaved
ACKmutants were further purified by gel filtration (S75 16/60
and S30 16/60, respectively; GE Healthcare), whereas GST–
ACK mutants were purified using ion exchange (Resource Q 1
ml; GE Healthcare). Protein concentrations were measured by
A280 using calculated extinction coefficients.
Nucleotide exchange
Cdc42 was labeled with [3H]GTP as follows. [3H]GTP
(PerkinElmer Life Sciences) was dried by centrifugal evapora-
tion, and 0.7mg of Cdc42, 15 nM phosphoenol pyruvate, 6 units
pyruvate kinase (Sigma-Aldrich), 15 mM KCl, and 0.36 M
(NH4)2SO4 were added in 140 l of buffer (10 mM Tris–HCl,
150 mM NaCl, 1 mM DTT, pH 7.5). The mix was incubated at
37 °C for 3 h, afterwhich 10mMMgCl2was added to quench the
reaction. Unbound nucleotide was removed with Sephadex
G25 spin columns (GE Healthcare).
SPAs
Direct binding—Affinities of ACK proteins for Cdc42 were
measured using SPA. 20 nM concentrations of individual ACK
mutants were immobilized on protein A SPA fluoromicro-
spheres via an anti-GST antibody (Sigma-Aldrich). The equi-
librium binding constants (Kd) of the effector–G protein inter-
action were determined by monitoring the SPA signal in the
presence of varying concentrations of [3H]GTP–Cdc42, as
described previously (21). Binding of Cdc42 to the effector
domain brings the radiolabeled nucleotide into proximity with
the scintillant, allowing a signal to be generated. For each ACK
mutant, a negative control was performed in the absence of
effector, which resulted in a linear increase in background SPA
counts. This data set was then subtracted from the data points
obtained in the presence of effector, and the adjusted values
were plotted as a function of increasing concentration of
Cdc42. For each affinity determination, data points were
obtained for at least eight different G protein concentrations.
Binding curves were fitted using a direct binding isotherm (33)
to obtain Kd values and their S.E. values for the G protein–
effector interactions.
Competition binding—In cases where binding of Cdc42 to
ACK mutants was relatively weak (reducing the quality of the
binding curve fit), the mutants were used to compete with the
interaction between WT ACK GBD and Cdc42. 30 nM WT
ACK was immobilized on protein A SPA fluoromicrospheres
via an anti-GST antibody (Sigma-Aldrich). 30 nM Cdc42 was
added, and the effect of competition was measured by measur-
ing the signal in the presence of increasing concentrations of
(GST-cleaved) ACK mutant peptide. SPA counts were mea-
sured at each concentration and fitted to the appropriate bind-
ing isotherm as described (27).
Bio-layer inferometry
The interactions between Cdc42 and GST fusion constructs
of ACK,WASP, and a basic regionmutant ofWASPwere stud-
ied using bio-layer inferometry on an Octet Red system (Forte-
Bio). Experiments were performed in 50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 1 mM MgCl2, 0.02% Tween 20, 0.1% BSA, and
0.05% sodium azide at 25 °C. Anti-GST sensors were loaded
with GST fusion proteins at concentrations of 10 g/ml,
washed to return to baseline, and then dipped into a dilution
range of Cdc42GMPPNP to measure association. Dissociation
was measured by dipping sensors into buffer after the associa-
tion step. Tominimize the effects of nonspecific binding, bind-
ing data were collected for sensors loaded with GST alone, and
this was subtracted from the experimental traces. Sensors were
regenerated in 10 mM glycine, pH 2, for reuse. Analysis was
undertaken using the Octet Red analysis software.
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